Financiere de Tubize SA

FTD

Company Profile

  • Business description

    Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

  • Contact

    Allee de la Recherche, 60
    Brussels1070
    BEL

    T: +32 497515208

    https://www.financiere-tubize.be

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    250

Stocks News & Analysis

stocks

Lowering profit forecasts on Aussie airlines

The impact of the oil price surge.
stocks

AI isn’t an economic moat killer, but it will disrupt industries

How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,571.30125.30-1.44%
CAC 407,743.9217.720.23%
DAX 4022,636.9116.95-0.07%
Dow JONES (US)46,300.2391.760.20%
FTSE 1009,965.1671.010.72%
HKSE25,063.71681.242.79%
NASDAQ21,842.29104.47-0.48%
Nikkei 22552,252.28736.791.43%
NZX 50 Index12,701.75288.24-2.22%
S&P 5006,578.712.29-0.03%
S&P/ASX 2008,379.40125.20-1.47%
SSE Composite Index3,881.2868.001.78%

Market Movers